Tech Observer Strengthens its presence in APAC Region

Tech Observer Strengthens its presence in APAC Region

Tech Observer acquired majority interest in local Singapore CRO called R2T (Research2Trials Clinical Solutions Pte Ltd); strengthening its foothold in Asia Pacific region. It boosts Tech Observer operations in major Asian Pacific countries including China. The acquisition enhances Tech Observer scope to utilize the experience & resources of R2T in the APAC region and providing it's client more local interaction and comfort.  

R2T has tremendous technical & cultural knowledge and understanding of Asian market, giving more edge to the global experience of Tech Observer.  R2t has robust track record of executing clinical studies in Singapore & other Asian countries. Also Singapore act as a central location for easy networking in regional countries and it is also a medical hub for healthcare industry. As center of gravity of clinical studies is shifting from west to east; so it’s a strategy of Tech Observer to solidify its position in Asia Pacific. It will intensify its clinical development solutions in all therapeutic areas and broadens Tech Observer global coverage.